Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 July 2022 | Story Andre Damons | Photo Supplied
Prof Martie Smith and Prof Drik Opperman
Prof Martie Smit and Prof Dirk Opperman in the Department of Microbiology and Biochemistry filed a patent entitled “Process for the chemical modification of alkanes, fatty acids and fatty alcohols”.

Flavours and fragrances have a wide application in the food, feed, cosmetic, chemical and pharmaceutical sectors. Many flavour compounds are still produced via chemical synthesis or via extraction from plant or animal sources. However, there is increasing interest in their bio-production or the use of flavour compounds of (micro) biological origin. 

One reason for this shift is that chemical synthesis often uses environmentally unfriendly processes. Chemical synthesis usually also produces racemic mixtures with the second enantiomer, mirror image of the looked-for compound, often having undesirable organoleptic properties. Furthermore, the consumer has developed a “chemophobia”-attitude towards synthetic chemical compounds, especially when related to food and home-care products.  This applies even to nature-identical compounds – products that occur in nature but are produced via a non-natural chemical process. Products produced with the use of enzymes or microbes from “natural” substrates can be labelled “natural”. The flavour and fragrance industry thus pay higher prices for such products labelled as “natural”.  

The invention

A University of the Free State (UFS) team, led by Prof Martie Smit and Prof Dirk Opperman in the Department of Microbiology and Biochemistry are conducting exciting research in this area. They filed a patent entitled “Process for the chemical modification of alkanes, fatty acids and fatty alcohols”.  

The invention relates to a process for the enzymatic in-chain hydroxylation of C12 to C16 fatty acids, alcohols, and alkanes. Hydroxylation of C12 fatty acid and alcohol provides routes for the synthesis of “natural” δ-dodecalactone. The advantage of these routes is that they do not rely on massoia lactones. Massoia lactones are derived from the bark of Massoia trees which grow in Indonesia. Harvesting of the bark kills the trees.  

The cytochrome P450 enzymes (P450s) claimed in this patent are to the inventors’ knowledge the most regioselective enzymes described thus far that can be used for the synthesis of δ-dodecalactone from lauric acid or 1-dodecanol. The approach that the technology takes is to claim cytochrome P450 enzymes that share 70 % amino acid identity to a set of selected P450s for the regioselective hydroxylation of lauric acid and 1-dodecanol to synthesise δ-dodecalactone.

Still in early stage

The current state of development is early stage with the technology only demonstrated in the laboratory on a small scale (100-200 ml). Before the technology can be commercialised the team would need to further improve the regioselectivity and stability of the P450s and proof that the reactions can be scaled up in bioreactors. The technology will probably be delivered as an enzyme (amino acid sequence) with the desired properties. 

There are other research groups working on a synthetic biology approach for the de novo synthesis of δ-dodecalactone from glucose by genetically engineered microbes. It is still unclear how such a process will compare in terms of product yields, economics and environmental impact with the processes proposed by the UFS patent.

If the team had to partner with a commercial company, their first choice would be to work with an established flavour and fragrance company. Another possibility would be the small French flavour and fragrance company that Dr Alizé Pennec, the post-doc and co-inventor who initially discovered the unique P450 activity, is working for.

Please view the videos for more information on patents.

The Vice-Rector: Research and Internationalisation has released two new calls for applications for funding. Academic staff and researchers are encouraged to submit applications for these funds. At this stage we are not accepting projects from Research Fellows. 

The two funds are: 

1.  The Industrial Engagement Fund 
2.  The Intellectual Property Commercialisation Fund

Each fund has its own guidelines and application process. The guidelines are attached. The applications must be filled in on RIMS.

The RIMS application forms can be found through this link

For more information please click the documents below:



News Archive

Care centre goes high-tech to help sexual abuse victims
2016-11-25

Description: Colposcope Tags: Colposcope

The colposcope, donated by the Discovery Fund,
will be used during gynaecological examinations
to detect any irregularities.
Photo: Supplied

Rape is one of South Africa’s most pressing social problems. Rape levels in the country are often discussed and reported on, but it does not deter perpetrators from this behaviour. According to Africa Check, of the more than 42 000 rape cases reported in 2015, 15 790 were child rape cases.

In an effort to assist victims of sexual assault and rape, the University of the Free State (UFS) Department of Family Medicine adopted the Tshepong Thuthuzela Care Centre, under the leadership of UFS lecturer Dr Mariaan Kotze.

The Discovery Fund donated a colposcope to Tshepong Thuthuzela Care Centre, an instrument that works with the help of a bright light and which is used to examine victims of abuse. It has also become a standard of good practice in the assessment of child abuse worldwide. According to Dr Kotze, the new instrument will also be used for training health practitioners by rendering clinical forensic services to abuse victims.

Managing complex issues

The care centre works with between 80 and 120 victims of rape each month, a third of whom are children under 14 years of age. According to Dr Kotze, the management of child sexual abuse victims is more complex than with adults; as there is a higher chance of missing or over-diagnosing abnormalities. Also, she says, the examination process is often observed by a group of healthcare practitioners, an experience which is often intrusive and intimidating for the child. With the colposcope, the timeframe of the examination is shortened, and can be captured and viewed in real time, without the victim being present.

Best care for victims

The colposcope is a magnifier and light source used during gynaecological examinations. It is instrumental in providing the best care to victims of sexual abuse, and helps diagnose and assist in the treatment of cases of abuse. Its ability to capture and review images at the time of examination allows for retrospective research, and improves the ability of expert witnesses in court cases.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept